These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 10676658

  • 1. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
    Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL.
    Cancer Res; 2000 Feb 01; 60(3):712-21. PubMed ID: 10676658
    [Abstract] [Full Text] [Related]

  • 2. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL, Jones D, Taylor G, Jaworski K, Kelly DJ, Ludbrook SB, Willette RN, Kumar S, Gilbert RE.
    Invest Ophthalmol Vis Sci; 2006 Apr 01; 47(4):1600-5. PubMed ID: 16565398
    [Abstract] [Full Text] [Related]

  • 3. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line.
    Santoni G, Spreghini E, Lucciarini R, Amantini C, Piccoli M.
    Microb Pathog; 2001 Oct 01; 31(4):159-72. PubMed ID: 11562169
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
    Davison E, Kirby I, Whitehouse J, Hart I, Marshall JF, Santis G.
    J Gene Med; 2001 Oct 01; 3(6):550-9. PubMed ID: 11778901
    [Abstract] [Full Text] [Related]

  • 5. Vitronectin decreases microvascular endothelial cell apoptosis.
    Isik FF, Gibran NS, Jang YC, Sandell L, Schwartz SM.
    J Cell Physiol; 1998 May 01; 175(2):149-55. PubMed ID: 9525473
    [Abstract] [Full Text] [Related]

  • 6. Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release.
    Sokolova O, Heppel N, Jägerhuber R, Kim KS, Frosch M, Eigenthaler M, Schubert-Unkmeir A.
    Cell Microbiol; 2004 Dec 01; 6(12):1153-66. PubMed ID: 15527495
    [Abstract] [Full Text] [Related]

  • 7. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo.
    Hall H, Djonov V, Ehrbar M, Hoechli M, Hubbell JA.
    Angiogenesis; 2004 Dec 01; 7(3):213-23. PubMed ID: 15609076
    [Abstract] [Full Text] [Related]

  • 8. Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways.
    Erdreich-Epstein A, Tran LB, Cox OT, Huang EY, Laug WE, Shimada H, Millard M.
    Blood; 2005 Jun 01; 105(11):4353-61. PubMed ID: 15705795
    [Abstract] [Full Text] [Related]

  • 9. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
    Carron CP, Meyer DM, Pegg JA, Engleman VW, Nickols MA, Settle SL, Westlin WF, Ruminski PG, Nickols GA.
    Cancer Res; 1998 May 01; 58(9):1930-5. PubMed ID: 9581835
    [Abstract] [Full Text] [Related]

  • 10. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.
    Carriero MV, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, Botti G, D'Aiuto G, Salvatore M, Stoppelli MP.
    Cancer Res; 1999 Oct 15; 59(20):5307-14. PubMed ID: 10537314
    [Abstract] [Full Text] [Related]

  • 11. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
    Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM.
    Nat Med; 2002 Jan 15; 8(1):27-34. PubMed ID: 11786903
    [Abstract] [Full Text] [Related]

  • 12. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death.
    Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL.
    Clin Cancer Res; 1999 Jun 15; 5(6):1587-94. PubMed ID: 10389948
    [Abstract] [Full Text] [Related]

  • 13. Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survival.
    Bieler G, Hasmim M, Monnier Y, Imaizumi N, Ameyar M, Bamat J, Ponsonnet L, Chouaib S, Grell M, Goodman SL, Lejeune F, Rüegg C.
    Oncogene; 2007 Aug 23; 26(39):5722-32. PubMed ID: 17369858
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of FGF-2-mediated chemotaxis of murine brain capillary endothelial cells by cyclic RGDfV peptide through blocking the redistribution of c-Src into focal adhesions.
    Shono T, Mochizuki Y, Kanetake H, Kanda S.
    Exp Cell Res; 2001 Aug 15; 268(2):169-78. PubMed ID: 11478843
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC, Malkowski M, Yin Z, Tanghetti E, Yaremko B, Nechuta T, Varner J, Liu M, Smith EM, Neustadt B, Presta M, Armstrong L.
    Cancer Res; 2001 Mar 01; 61(5):2232-8. PubMed ID: 11280792
    [Abstract] [Full Text] [Related]

  • 16. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA, Ziaie Z, Pasco S, Fawzi A, Bellon G, Monboisse JC, Kefalides NA.
    Cancer Res; 1999 Sep 15; 59(18):4584-90. PubMed ID: 10493512
    [Abstract] [Full Text] [Related]

  • 17. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
    Tang DG, Diglio CA, Honn KV.
    Cancer Res; 1994 Feb 15; 54(4):1119-29. PubMed ID: 8313370
    [Abstract] [Full Text] [Related]

  • 18. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
    Li L, Wartchow CA, Danthi SN, Shen Z, Dechene N, Pease J, Choi HS, Doede T, Chu P, Ning S, Lee DY, Bednarski MD, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1215-27. PubMed ID: 15001266
    [Abstract] [Full Text] [Related]

  • 19. Studies on the expression of alpha(v)beta3 integrin receptors in non-malignant and malignant human cervical tumor tissues.
    Chattopadhyay N, Chatterjee A.
    J Exp Clin Cancer Res; 2001 Jun 15; 20(2):269-75. PubMed ID: 11484986
    [Abstract] [Full Text] [Related]

  • 20. Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia.
    Abumiya T, Lucero J, Heo JH, Tagaya M, Koziol JA, Copeland BR, del Zoppo GJ.
    J Cereb Blood Flow Metab; 1999 Sep 15; 19(9):1038-50. PubMed ID: 10478656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.